Open Actively Recruiting

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

About

Brief Summary

The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.

Study Type
observational_patient_registry

Eligibility

Gender
All
Minimum Age
18 Years
Maximum Age
N/A

INCLUSION CRITERIA

  • Fluent in English or Spanish;
  • Age 18 and over;
  • Self-reported symptoms suggestive of acute SARSCOV2 infection;
  • Under investigation for SARSCOV2 (defined as a patient who has received any screening or diagnostic test used to detect the presence of COVID19 including any FDA approved or authorized molecular or antigen-based assay) within the last 42 days.

EXCLUSION CRITERIA

  • Unable to provide informed consent;
  • Study team unable to confirm result of diagnostic test for SARSCOV2;
  • Does not have access to a hand-held device or computer that would allow for digital participation in the study;
  • Individuals who are prisoners while participating in the study.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
20-001683
Category
General Medicine & Health Services
Recovered Patients
Contact
COVID19 INSPIRE Registry
Location
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT04610515
For detailed technical eligibility, visit ClinicalTrials.gov.